by measuring in vitro the effect of deproteinized plasma on canine kidney na+k+-atpase activity , evidence was sought for the presence of a circulating inhibitor of the enzyme in 31 patients with end-stage renal failure , 10 patients treated with digoxin , and 22 patients with untreated essential hypertension .
C0022646
kidney
C0022661
end-stage renal failure